Psivant Therapeutics

PsiThera is focused on developing oral therapies for immunology targets, particularly those within the tumor necrosis factor (TNF) superfamily, where no oral treatments currently exist. Utilizing their QUAISAR platform, they model biologically relevant protein motion to identify druggable states and design small molecules for diseases typically tre... ated with injected biologics. Their innovative approach combines computational intelligence and integrated structural biophysics to enhance drug discovery and decision-making processes. PsiThera aims to provide patients with effective oral medications that offer biologic-like efficacy without the need for injections.Read More